<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/V/Vinorelbine.html">
<title>Vinorelbine RSS : Gourt</title>
<link>http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/V/Vinorelbine.html</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:rights>Copyright 2007, Gourt.com</dc:rights>
<dc:date>2009-11-05T12:07+44:00
</dc:date>
<dc:publisher>rtruog@gourt.com</dc:publisher>
<dc:creator>rtruog@gourt.com</dc:creator>
<dc:subject>Vinorelbine RSS : Gourt</dc:subject>
<syn:updatePeriod>hourly</syn:updatePeriod>
<syn:updateFrequency>1</syn:updateFrequency>
<syn:updateBase>1901-01-01T00:00+00:00</syn:updateBase>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://twitter.com/MDLinx/statuses/5448047639" />
  <rdf:li rdf:resource="http://twitter.com/trialscentral/statuses/5397989364" />
  <rdf:li rdf:resource="http://twitter.com/trialscentral/statuses/5397624438" />
  <rdf:li rdf:resource="http://twitter.com/trialscentral/statuses/5236214560" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://twitter.com/MDLinx/statuses/5448047639">
<title>Heme/Onc: Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzum http://url4.eu/hNxB</title>
<link>http://twitter.com/MDLinx/statuses/5448047639</link>
<description><![CDATA[Heme/Onc: Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzum http://url4.eu/hNxB]]></description>
</item>

<item rdf:about="http://twitter.com/trialscentral/statuses/5397989364">
<title>A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer   http://bit.ly/2aam9S</title>
<link>http://twitter.com/trialscentral/statuses/5397989364</link>
<description><![CDATA[A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer   http://bit.ly/2aam9S]]></description>
</item>

<item rdf:about="http://twitter.com/trialscentral/statuses/5397624438">
<title>Study With Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer  http://bit.ly/2sVEou</title>
<link>http://twitter.com/trialscentral/statuses/5397624438</link>
<description><![CDATA[Study With Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer  http://bit.ly/2sVEou]]></description>
</item>

<item rdf:about="http://twitter.com/trialscentral/statuses/5236214560">
<title>Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse   http://bit.ly/2t6teG</title>
<link>http://twitter.com/trialscentral/statuses/5236214560</link>
<description><![CDATA[Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse   http://bit.ly/2t6teG]]></description>
</item>

</rdf:RDF>